TELA Bio, Inc. Deferred Tax Assets, in Process Research and Development
TELA Bio, Inc. (TELA) had Deferred Tax Assets, in Process Research and Development of $1.04 million as of 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment · last filed 2026-03-25
- 2025-12-31: Deferred Tax Assets, in Process Research and Development $1.04M.
- 2024-12-31: Deferred Tax Assets, in Process Research and Development $830.00K.
- 2023-12-31: Deferred Tax Assets, in Process Research and Development $830.00K.
- 2022-12-31: Deferred Tax Assets, in Process Research and Development $623.00K.
| Period end | Deferred Tax Assets, in Process Research and Development |
|---|---|
| 2025-12-31 | $1.04M 10-K · filed 2026-03-25 |
| 2024-12-31 | $830.00K 10-K · filed 2026-03-25 |
| 2023-12-31 | $830.00K 10-K · filed 2025-03-21 |
| 2022-12-31 | $623.00K 10-K · filed 2024-03-22 |
| 2021-12-31 | $623.00K 10-K · filed 2023-03-23 |
| 2020-12-31 | $747.00K 10-K · filed 2022-03-23 |
| 2019-12-31 | $853.00K 10-K · filed 2021-03-25 |
| 2018-12-31 | $701.00K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |